Parameter | Definition | Value | Reference |
L | Lattice size | 250 | Ad hoc |
H_PR | Production rate of normal healthy CD4+T cell | 18 cells/iteration | [17] |
CTL_PR | Production rate of CTLs | 30 cells/iteration (in primary infection phase) & 3 cell every 14 iterations (after the end of primary infection phase) | [17] [18] |
AB_PR | Production rate of Anti Bodies | 50 cells/iteration (in primary infection phase) & 5 cell every 14 iterations (after the end of primary infection phase) | [17] [18] |
H_LSL | Life span limit of normal Healthy CD4+T cells | 4 iterations | [17] |
CTL_LSL | Life span limit of CTLs | 15 iterations | [17] [18] |
AB_LSL | Life span limit of Anti Bodies | 15 iterations | [18] |
V_LSL | Life span limit of HIVInfectious | 3 iterations | [17] |
R | Number of infected A2 cells in the neighborhood of a healthy CD4+T cell which makes converting a healthy cell into an A1 infected cell | 4 cells | [12] |
TRe-activation | Delay time needed to re-activate the A0 latently infected cells | 30 iterations | [14] |
Pinf | The probability of converting a healthy cell into an A1 cell in the presence of infecting factors | 0.99 | [14] |
Preplication | The probability of replacing a dead cell by a normal healthy cell | 0.99 | [12] |
Pnew-infection | The probability of replacing each new healthy cell by an A1 infected cell | 10-5 | [12] |
Pidentification | The probability of identifying an infected A1 cell by CTLs | 55%, 75% and 95% respectively 3, 4 and 5 weeks after infection | Ad hoc |
PAB-identification | The probability of identifying an HIVInfectious by Anti Bodies | 0.95% | Ad hoc |
PHIV-PR | The probability of releasing an HIVInfectious particle from an A1 infected cell | 0.99 | [19] |
PRe-activation | The probability of reactivating an A0 cell after a specified period of time. | 0.0005 | [14] |
PPI & PRTI | The effectiveness of PI and RTI antiretroviral drugs | Varies between 0 to 0.9 | [15] |